Medtrum Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
78
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
Medtrum General Information
Description
Manufacturer of diabetes management medical devices intended for patients and healthcare professionals. The company's range of products includes insulin pump systems, continuous glucose monitoring devices, glucose and insulin management software, wearable medical devices and artificial pancreas research tools, enabling accurate glucose monitoring, automated insulin delivery, and improved day to day diabetes management.
Contact Information
Website
www.medtrum.comCorporate Office
- Building 8
- Number 200 Niudun Road
- Shanghai, 201203
- China
Corporate Office
- Building 8
- Number 200 Niudun Road
- Shanghai, 201203
- China
Medtrum Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 11-Feb-2025 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 25-Nov-2022 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 15-Jul-2022 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 24-Dec-2018 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 16-Nov-2014 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 31-Mar-2010 | Completed | Generating Revenue |
Medtrum Patents
Medtrum Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1137635-S1 | Insulin infusion device | Active | 22-Jul-2025 | ||
| WO-2026107792-A1 | Blood glucose management system | Pending | 25-Nov-2024 | ||
| WO-2026107790-A1 | Blood glucose management system for establishing wireless communication connection on basis of signal strength | Pending | 25-Nov-2024 | ||
| WO-2026107791-A1 | Blood glucose management system for establishing wireless communication connection on basis of signal strength | Pending | 25-Nov-2024 | ||
| WO-2026065103-A1 | Miniaturized mounting unit of analyte detection apparatus | Pending | 27-Sep-2024 |
Medtrum Signals
Medtrum Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3E Bioventures (China) | Venture Capital | Minority | ||
| Morningside Group | Venture Capital | Minority | ||
| Shanghai Nuokai Asset Management | Venture Capital | Minority |
Medtrum FAQs
-
When was Medtrum founded?
Medtrum was founded in 2008.
-
Where is Medtrum headquartered?
Medtrum is headquartered in Shanghai, China.
-
What is the size of Medtrum?
Medtrum has 78 total employees.
-
What industry is Medtrum in?
Medtrum’s primary industry is Monitoring Equipment.
-
Is Medtrum a private or public company?
Medtrum is a Private company.
-
What is Medtrum’s current revenue?
The current revenue for Medtrum is .
-
How much funding has Medtrum raised over time?
Medtrum has raised $29M.
-
Who are Medtrum’s investors?
3E Bioventures (China), Morningside Group, and Shanghai Nuokai Asset Management have invested in Medtrum.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process